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Abstract
Plasmodium vivax is the most prevalent malarial species in South America and exerts a
substantial burden on the populations it affects. The control and eventual elimination of P.
vivax are global health priorities. Genomic research contributes to this objective by improv-
ing our understanding of the biology of P. vivax and through the development of new genetic
markers that can be used to monitor efforts to reduce malaria transmission. Here we ana-
lyze whole-genome data from eight field samples from a region in Cordóba, Colombia
where malaria is endemic. We find considerable genetic diversity within this population, a
result that contrasts with earlier studies suggesting that P. vivax had limited diversity in the
Americas. We also identify a selective sweep around a substitution known to confer resis-
tance to sulphadoxine-pyrimethamine (SP). This is the first observation of a selective
sweep for SP resistance in this species. These results indicate that P. vivax has been
exposed to SP pressure even when the drug is not in use as a first line treatment for patients
afflicted by this parasite. We identify multiple non-synonymous substitutions in three other
genes known to be involved with drug resistance in Plasmodium species. Finally, we found
extensive microsatellite polymorphisms. Using this information we developed 18 polymor-
phic and easy to score microsatellite loci that can be used in epidemiological investigations
in South America.
Author Summary
Although P. vivax is not as deadly as the more widely studied P. falciparum, it remains a
pressing global health problem. Here we report the results of a whole-genome study of P.
vivax from Cordóba, Colombia, in South America. This parasite is the most prevalent in
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this region. We show that the parasite population is genetically diverse, which is contrary
to expectations from earlier studies from the Americas. We also find molecular evidence
that resistance to an anti-malarial drug has arisen recently in this region. This selective
sweep indicates that the parasite has been exposed to a drug that is not used as first-line
treatment for this malaria parasite. In addition to extensive single nucleotide and micro-
satellite polymorphism, we report 18 new genetic loci that might be helpful for fine-scale
studies of this species in the Americas.
Introduction
Despite significant advancements toward malaria control and elimination, about 40% of the
world’s population remains at risk of infection by one of the four protozoan species that com-
monly cause the disease [1]. Among the human malarias, P. vivax is the parasite with the most
morbidity outside Africa [1]. P. vivax differs from the more widely studied P. falciparum in
aspects of its life cycle, disease severity, geographic distribution, ecology, and evolutionary his-
tory [2–7], raising concerns that gaps in our knowledge about its basic biology may compro-
mise its control (see [8] for a detailed discussion).
Genomic approaches provide important tools to study hard-to-culture parasites such as P.
vivax. For example, genome-wide scans performed on samples from a natural parasite popula-
tion can identify regions of the genome subject to strong selection. Studies using this approach
in P. falciparum have contributed to the study of drug resistance and adaptation to the host
immune system in that species [9–12]. However, this approach has not yet been widely applied
in P. vivax.
Previous population genetic studies have found that P. vivax populations in many regions of
the Americas are less diverse than those from Asia or Oceania [8, 13–17]. Similarly, a recent
whole-genome study found limited genetic diversity in a population from the Amazon basin of
Peru [18]. It remains unclear whether these results are reflective of populations in the New
World generally, the geographical sampling of those particular studies, or the loci sampled in ear-
lier studies. Two recent studies have suggested that P. vivax populations in the Americas may
harbor more genetic diversity than previously thought. First, a genome-wide comparison
revealed substantial genetic divergence among three parasite lineages isolated in the Americas
and maintained in non-human primates [19]. Second, recent population studies on the mito-
chondrial genome have shown high levels of divergence and limited gene flow among popula-
tions in the region [20]. This pattern indicates that P. vivax populations in the Americas likely
have a complex history, with divergent populations harboring differing levels of genetic diversity.
Genomic studies can also support efforts to control and eliminate malaria from a given
region by identifying genetic markers that will be informative for fine-scale population genetic
studies in that region. Molecular epidemiological investigations rely on multilocus genotyping
of SNPs or microsatellites [21] to investigate patterns of population structure and gene flow.
Although the high mutation rates of microsatellite loci makes them ideal markers for such
studies, only a few loci are currently in use [21]. These existing loci were developed using data
from a small number of populations. As a result, some of these loci fail to amplify in samples
from other localities [22]. Whole-genome studies offer the opportunity to identify new loci
that are both polymorphic in a given region and able to be score reliably (e.g. by selecting loci
with simple repeat motifs). In addition to identifying patterns of transmission within a region,
these markers can be used to distinguish local cases (the result of remaining malaria transmis-
sion) from those that are introduced from another region. Ascertaining the source of the
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parasites detected in a given case is critical for evaluating the success of interventions during an
elimination program.
Here we take a whole-genome approach to characterize the genetic variation of field isolates
from single-lineage P. vivax infections from Northern Colombia (specifically, Tierralta,
Department of Córdoba), an area in South America with seasonal transmission [23]. In addi-
tion to assessing the genetic diversity within this population, we examine patterns of diversity
across the P. vivax genome and find evidence for a recent selective sweep likely associated with
resistance to a drug that is not prescribed for treating P. vivaxmalaria. We also develop 18 new
microsatellite loci for fine scale studies in Colombia.
Methods
Ethics statement
A passive surveillance study was conducted between 2011 and 2013 in outpatient clinics located
in Tierralta [23]. The study protocol was approved by the Institutional Review Board (IRB) affil-
iated to the Malaria Vaccine and Drug Development Center (MVDC, Cali-Colombia). Patients
with malaria infections containing more than 5,000 parasites per μL of blood, as determined by
microscopic examination of Giemsa-stained thick blood smears, received oral and written
explanations about the study and, after expressing their willingness to participate, were
requested to sign an informed consent (IC) previously approved by the Institutional Review
Board (IRB) affiliated to the MVDC. IC from each adult individual or from the parents or
guardians of children under 18 years of age was obtained. Individuals between 7 and 17 years
old were asked to sign an additional informed assent. A trained physician of the study staff com-
pleted a standard clinical evaluation and a physical examination in all malaria symptomatic sub-
jects. The local health provider treated individuals as soon as the blood sample had been drawn,
using national antimalarial therapy protocol of the Colombian Ministry of Health and Social
Protection [23]. Specifically, patients infected with P. vivax were treated orally with chloroquine
(25 mg per kg provided in three doses) and primaquine (0.25 mg per kg daily for 14 days).
Sample collection
A brief description of each patients infection status and medical history is provided in S1 Table.
We collected 10 mL of blood from each patient and stored each blood sample in EDTA. In order
to eliminate as much human DNA as possible, each sample was diluted in one volume of PBS
and filtered with a CF11 column ( 3g) that had previously been rinsed with PBS. A new column
was used for each 5 mL of sample. Each filtered sample was centrifuged at 1,000 g for 10 minutes.
The supernatant was discarded and the red blood cells (RBC) were kept at −20°C and sent to our
laboratory in Cali for processing. The RBCs were suspended in one volume of PBS and aliquoted
into 200 μL fractions. DNA was extracted from each aliquot using a PureLink Genomic DNA kit
(Invitrogen, USA) following the specifications provided by the manufacturer.
Sequencing and alignment to reference
Depending on the availability and quality of the sample, we used between 300 ng and 1 mg of
DNA to construct sequencing libraries. These libraries were constructed using a Kapa Biosys-
tems DNA Library Preparation Kit (Kapa Biosystems, USA). The resulting fragments were
amplified in ten rounds of PCR, using a Kapa HiFi Library Amplification Kit (Kapa Biosys-
tems, USA). Denaturation and clustering were performed using an Illumina cBot. Once the
samples were clustered, the flow cell was loaded onto a HiSeq 2000. The run module used was
Colombian Plasmodium vivaxGenomes Have Substantial Genetic Diversity
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004252 December 28, 2015 3 / 21
a paired end 2×100 reads. All sequencing and library preparation stages were performed by the
DNASU sequencing core at Arizona State University.
We used Bowtie version 2.1.0 [24] to map reads from each sample to a reference genome
containing sequences derived from the Salvador I (SalI) strain’s nuclear [25] (build
ASM241v1) and apicoplast [26] genomes. The resulting alignments were processed using a
modified version of the GATK project’s best practice guidelines [27]. Specifically, we identified
and marked potential PCR duplicates using the MarkDuplicates tool from Picard version 1.106
(http://picard.sourceforge.net) and performed local realignment around possible indels using
GATK 2.8 [28, 29]. Finally, we adjusted the raw base quality scores by running GATK’s Base-
Recalibrator tool, treating the set of putative Single Nucleotide Variants (SNVs) identified by
SAMtools (0.1.18) [30] as known variants.
To investigate the possibility that our patient samples contain multiple distinct P. vivax
strains [31, 32], we repeated this process using sequencing reads produced from a known single
infection. We retrieved reads from the monkey-adapted Sal-1 strain [31] from the NCBI
Sequence Read Archive (accession SRS365051) We recorded the frequency of bases matching
the reference genome at each site for the patient-derived and single lineage alignments using a
custom C++ program (http://dx.doi.org/10.5281/zenodo.18190) that makes use of the Bam-
Tools [33] library. For each sample, we also calculated the overall proportion of all sequenced
bases that produced a minority allele when mapped to the reference.
Variant discovery
We called putative SNVs and small indels from the Colombian samples using the GATK Uni-
fiedGenotyper [28]. Because we were able to establish that each patient was infected by a single
lineage, we treated samples as haploid. Artifacts produced during the sequencing and mapping
of reads to the reference can lead to false positive variant calls [34]. Such calls are more likely in
P. vivax due the number of multi-copy gene families and paralogs in this species [35]. In order
to account for these potential artifacts, we took a conservative approach to variant calling and
removed apparently variant sites that may have resulted from mis-mapped reads. After per-
forming an exploratory analysis comparing properties of our putative variants to a random
sample of 100,000 non-variant sites, and using guidelines described by the GATK developers
[29] we established a set of criteria to identify likely false positive variants. Specifically, we
removed sites with an average mapping quality phred score<35. We controlled for the effect
of repetitive sequences by removing sites within 50 kb of a chromosome ends (which are domi-
nated by repeats) and those sites for which more than one sample generated more than two
reads containing a minor nucleotide. Finally, we excluded sites with extreme values for a num-
ber statistics that correlate with genotype quality. We removed sites matching any of the fol-
lowing criteria: (a) the P-value for a Fisher’s exact test of strand bias was<0.001, (b) the
absolute z-score for a Mann-Whitney U-test of mapping quality difference between variant
and reference allele containing reads was>5, (c) the absolute z-score for a Mann-Whitney U-
test of read-position difference between variant and reference allele containing reads was>5,
(d) the total depth at site was 165x (the 95th percentile across all sites).
We identified putative microsatellite loci by searching for indels labled as Short Tandem
Repeats by UnifiedGenotyper. To produce a set of loci that are seggregating within Colombia
and likely to have relatively simple evolutionary histories we filtered putative microsatellites by
removing any loci that (a) were monomprhic within our sample, (b) had non-perfect repeats
or (c) had a repeat motif>8bp.
We produced final variant sets for SNVs and microsatellites by removing all sites that
matched at least one of the criteria listed above using PyVCF (http://pyvcf.readthedocs.org/).
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We produced a functional annotation for each polymorphic SNV with snpeff [36] using the
Ensembl functional annotation of the Sal-I reference (build ASM241v1.23) as input.
Validation of variants
We validated our SNV calling procedure by running the steps described above on a genome
alignment generated from reads previously produced from the Sal-I strain [31] Because these
reads represent an independent sequencing of the same strain that was used to produce the ref-
erence genome, we expect very few non-reference alleles. We also tested the effect of including
low-coverage samples in our variant calling pipeline by repeating this procedure with the Sal-I
alignment down-sampled to 2x coverage. We further tested the validity of filtered variant sites
by searching for apparently singleton SNVs (those found only once in our population sample)
in previously reported SNVs from other studies [19, 31].
Oligonucleotide primers for polymorphic microsatellites DNA markers
We designed PCR primers for 18 of the microsatellite loci identified using the above criteria.
We first chose a subset of these putative microsatellites that were distributed across different P.
vivax chromosomes, then developed markers using two strategies. First, nine loci were identi-
fied on alignments of conserved regions between the P. cynomolgi and P. vivax genomes. (Sal-I
P. vivax genome data available in NCBI). Second, nine loci were identified on conserved
regions between Sal-I strain and Colombian samples from Tierralta.
All the alignments were made using ClustalX v2.0.12 and Muscle as implemented in Sea-
View v4.3.5 [37–39]. Dyes Hex and 6-FAM were used for labelling the forward primers. A
complete characterization of the 18 microsatellite loci and the primers we used to amplify
them is provided in S1 Text and S2 Table.
Population genetics
We calculated p^ andWatterson’s estimator of the population mutation rate y^w for the whole
genome, distinct genomic features (i.e. sequences falling in exons, intron, untranslated regions
and intergenic regions), and in 10 kb windows across each chromosome. We accounted for the
varying levels of sequence coverage among our samples by using missing-data estimators for
these measures [40]. Rather than setting an arbitrary coverage level at which a sample should
be considered missing for a given site, we used our data and variant calling approach to identify
the number of samples from which we could call a variant if it was present at each site in the
genome. We first created new “reference genome” sequences by switching each unambiguous
base in the Sal-I reference following Table 1. We then called variants against these “shifted”
genomes using the same procedure described above (including filtering steps). At each site, a
sample was considered missing if no variant could be called for that sample using the true ref-
erence genome or any of the shifted references.
We used PyBedtools [41, 42] to generate genomic windows, and extract polymorphisms
from various sequence classes. We used diversity statistics calculated from genomic windows
Table 1. Scheme used to produced alternative reference genomes.
Reference A C G T
First shift T A C G
Second shift G T A C
Third shift C G T A
doi:10.1371/journal.pntd.0004252.t001
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to identify genomic regions with unusually high or low genetic diversity. Specifically, we identi-
fied windows with values in the 1st or 99th percentile of either measure, having first removed
windows for which less than 85% of sites were callable. We discovered a region of particularly
low diversity surrounding the dhps gene, so focused on this gene by calculating each statistic
for the set of overlapping windows, each 10 kb wide and 500 bp apart from each other.
Results
Genome sequencing
We generated between 18 and 36 million paired-end reads from each sample (Table 2). Obtain-
ing genomic sequences from clinical isolates of P. vivax is complicated by the presence of
human DNA in parasite-containing blood samples. Although we took steps to remove leuko-
cytes from each of our samples, the proportion of reads that could be mapped to the Sal-I refer-
ence genome differed markedly among samples, ranging from<1%–28%. These differences
were reflected in the mean sequencing coverage achieved for each sample, which varies from
less than one read per base in sample 500, to greater than 40 reads for sample 499.
Despite the presence of some poorly covered samples, our mapped reads allow comparison
between multiple individuals for the vast majority of the P. vivax genome (Fig 1). Because low-
coverage samples still provide valuable data for variant calling at some sites and can often be
reliably genotyped for those sites known to contain segregating variants, we included all of our
patient samples in subsequent analyses.
All sampled patients were infected by only one P. vivax strain
The presence of multiple distinct parasite lineages within a single host has presented a barrier
to population genetic analysis in previous whole-genome studies of P. vivax. Because Plasmo-
diummerozoites are haploid in the vertebrate host, the presence of such multiple infections in
a patient can be inferred by the presence of multiple alleles at different loci. In the context of
high-throughput sequencing, these additional alleles manifest as an excess of bases with inter-
mediate frequencies at sites in a genome alignment. This result contrasts with the distribution
expected from singly infected patients, where only rare sequencing errors will produce minor-
ity bases [31]. We tested our samples for multiple infections by comparing the distribution of
minor base frequencies in our alignments with the same distribution in an alignment produced
from a known single infection (Fig 2). In both the known single infection strain and our
Table 2. Summary of sequencing data.
Sample Reads (millions) Proportion of reads mapped to Sal-I Mean Coverage p5 p10 p20 Proportion of minority bases
446 27.754 0.007 1.7 0.041 0.001 0.000 7.3 × 10−4
494 33.337 0.043 10.9 0.972 0.733 0.064 1.11 × 10−3
495 29.129 0.084 19.8 0.993 0.979 0.636 8.5 × 10−4
496 35.048 0.106 29.5 0.994 0.990 0.952 1.1 × 10−4
498 24.365 0.010 1.9 0.075 0.001 0.000 7.8 × 10−4
499 18.224 0.278 42.1 0.995 0.993 0.986 9.1 × 10−4
500 25.050 0.004 0.8 0.005 0.000 0.000 7.6 × 10−4
503 23.108 0.066 12.2 0.9830 0.825 0.100 9.1 × 10−4
“p5”, “p10” and “p20” refer to the proportion of sites covered by at least 5, 10 and 20 reads respectively.“Proportion of minority bases” refers to the
proportion of mapped-reads at a given site that contained a base that made up a minor fraction of all mapped bases.
doi:10.1371/journal.pntd.0004252.t002
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samples, minority bases were present only at low frequencies. This pattern contrasts distinctly
with the high proportion of intermediate-frequency bases expected from mixed infections [31].
Because the shape of the distribution of minor base frequencies will be less informative for
samples with low coverage, we also examined the proportion of all sequenced bases that were
in the minority relative to other reads aligned to the same site. Again, these results are similar
to those from Sal-I (Table 2). The proportion of minority bases in reads produced from a
known single infection was 7.3 × 10−4, while for our data this proportion was between
7.3 × 10−4 and 1.11 × 10−3. The fact that no samples had the base frequency-distributions char-
acteristic of mixed infections, and that the low-coverage samples did not produce more minor
bases than other samples, suggest that all of our samples can be considered single infections.
Fig 1. Summary of genomic data. Segments from outside to inside: P. vivax chromosomes with exonic regions shaded green; regions excluded from
variant calling in this study; heatmap of y^w in 10kb windows, high-diversity regions are darker and the maximum value is 0.0018; heatmap of p^ in 10kb
windows; mean number of samples covered per base in 10kb windows.
doi:10.1371/journal.pntd.0004252.g001
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Variant discovery
We validated our SNV calling procedure by applying it to a set of sequencing reads produced
independently from the same strain used to assemble the reference genome [31]. Using this
procedure, we called a total of 34 SNVs from the>22 million base pair reference genome, none
of which were called as polymorphic alleles in our patient-derived data. Repeating this proce-
dure with a lower coverage (2x) dataset generated fewer SNVs (18) including only one new
putative variant. The small number of variants called from the reference data confirms the con-
servative nature of our variant calling procedure.
In total, we identified 33,855 non-reference SNV alleles among the Colombian samples, of
which 3,594 were fixed difference and 30,261 of which were polymorphic (Table 3). The total
number of SNVs we detect is comparable to numbers found in studies of field isolates from
Fig 2. Reference base frequency spectra. The first eight panels represent the distribution of the frequency of reference bases in sequencing reads
produced from our samples across all sites in the P. vivax genome. In the final panel the same distribution is graphed for reads generated from Sal-I, a known
single infection. Red triangles represent the frequency expected if one non-reference containing read was mapped to a site with average sequencing
coverage for that sample (given in parentheses after the sample name). The majority of sites from all samples contain only non-reference bases; these sites
were removed to allow clearer visualization of these distributions.
doi:10.1371/journal.pntd.0004252.g002
Table 3. Summary of SNV data.
Total Exonic Intronic 3‘UTR 5‘UTR Intergenic
Number of SNVs 33855 16413 3107 808 1328 14333
Density 1.8 1.2 2.4 1.9 1.8 2.0
θw 7.0 × 10
−4 5.9 × 10−4 7.9 × 10−4 6.5 × 10−4 6.4 × 10−4 7.5 × 10−4
π 6.8 × 10−4 5.7 × 10−4 7.5 × 10−4 6.2 × 10−4 6.1 × 10−4 7.2 × 10−4
doi:10.1371/journal.pntd.0004252.t003
Colombian Plasmodium vivaxGenomes Have Substantial Genetic Diversity
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004252 December 28, 2015 8 / 21
other regions. The number of SNVs in our Colombian samples is slightly less than that from
samples fromMadagascan and Cambodian populations, which contained 41,630 and 45,417
SNVs respectively in the genomic regions included in our study (Fig 3) [31]; however, it was
three times the number identified in the same genomic regions in a recent study using isolates
from the Amazon basin in Peru [18]. Approximately two-thirds of the Peruvian SNVs (7,232)
are also present in our Colombian samples. The Madagascan and Cambodian samples share
many alleles that are absent in either South American population (11,618).
SNVs are relatively less common in exonic sites (1.2 SNVs per kb) than untranslated, intro-
nic or intergenic sites (1.8–2.4 SNVs per kb) (Table 3). The ratio of non-synonymous to synon-
ymous SNVs in exons is 1:1.51, a result that is lower than the 1:4 ratio predicted for the P.
vivax genome under neutrality [31]. This ratio, and the relative densities of SNVs in different
sequence classes, are very similar to those previously reported fromMadagascan and Cambo-
dian populations [31].
Among polymorphic SNVs, 12,913 (42.7%) were recorded in only one sample (Table 4).
However, many of these apparent singletons have been recorded in other studies. When we
compare our SNVs to a catalogue of previously reported P. vivax SNVs [18, 19, 31] only 6,854
(20.2%) are unique to this study. Our low-coverage samples did not produce more singletons
per callable-site than those with higher sequencing coverage (Table 4), suggesting the remain-
ing singletons are not simply artifacts introduced by including these samples.
We identified 789 putative microsatellite loci that met our filtering criteria. To demonstrate the
ability of whole-genome studies to develop new markers, we designed PCR primers for 18 of these
loci (choosing markers that were well-spread among the 14 P. vivax chromosomes). We were able
to generate PCR amplicons for each locus, and 16 were shown to be polymorphic within the vali-
dation panel, with between 2 and 4 loci segregating in this population (Table 5). The alleles of each
locus could be determined easily, as demonstrated by the electropherograms shown in S1 Fig.
Fig 3. Allele sharing among P. vivax populations. Note: Ellipses for Peruvian [18] Cambodian and
Madagascan [31] populations include only those SNVs reported in the cited studies and not included in a
region that was excluded in our study.
doi:10.1371/journal.pntd.0004252.g003
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Population genetics
Because each of our patient samples represents a single parasite lineage, we can use standard
population genetic analyses to investigate the evolutionary and demographic processes shaping
P. vivax genomes in Colombia.
We calculated two measures of genetic diversity: nucleotide diversity (p^) and Watterson’s
estimator (y^w) of the population mutation rate [43, 44]. Across the whole genome, we estimate
y^w to be 7.0 × 10
−4. The estimate for nucleotide diversity is slightly lower at 6.8 × 10−4. For
Table 4. Breakdown of singletons.
Sample Singletons this study Singletons all studies Callable sites
446 660 (78.7) 242 (28.9) 38.1
498 10 (1) 8 (0.8) 45.4
499 2974 (158.5) 1623 (86.5) 85.3
494 3134 (168.0) 1606 (86.1) 84.8
495 837 (44.7) 520 (27.8) 85.1
496 2361 (126.0) 1291 (68.9) 85.2
500 122 (35.3) 32 (9.3) 15.7
503 2806 (150.1) 1523 (81.4) 85.0
Total 12913 (111.9) 6854 (59.4) –
Values in parentheses are number of singleton SNVs per million callable sites.
Values in the Callable sites column are the proportion of all sites that were callable for a given sample.
doi:10.1371/journal.pntd.0004252.t004
Table 5. Summary of microsatellite loci discovered in this study.
Name Position Motif Repeats Alleles (genomes) Alleles (validation)
CLAIM1 2:96021 ATGC 5–7 4 4
CLAIM2 2:261105 AC 6–13 4 4
CLAIM3 5:280204 AACAGC 8–11 4 3
CLAIM4 5:1139547 AT 8–9 3 4
CLAIM5* 5:1195225 AAAT 6–10 4 4
CLAIM6* 5:1248584 AT 8–10 3 2
CLAIM7 6:436676 AT 8–9 3 1
CLAIM8* 7:761767 AT 8–9 3 2
CLAIM9 7:1343057 AG 8–12 3 1
CLAIM10* 8:439431 AT 8–10 4 4
CLAIM11 9:1048573 AAAT 6–7 3 4
CLAIM12* 9:1454922 AT 8–9 3 2
CLAIM13* 10:1348254 AT 8–9 3 2
CLAIM14 10:1368121 AT 3–8 3 3
CLAIM15 12:2076009 AC 7–11 4 3
CLAIM16* 12:2101147 AT 8–9 3 2
CLAIM17* 13:950389 AT 7–8 3 2
CLAIM18 14:1469652 AT 6–14 4 3
Loci marked with an asterisk were developed by comparing P. vivax sequences to P. cynmolgi. For the numbers of alleles, “genomes” refers to the
number identified from genomic data and “validation” to the number detected from the validation panel. PCR primers for each locus are given in S2 Table.
doi:10.1371/journal.pntd.0004252.t005
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both diversity measures, genetic diversity is lowest in exonic regions, then increasingly higher
in 30 and 50 untranslated regions of transcripts, intergenic regions, and introns (Table 3).
A selective sweep around dhps
We identified regions of the genome with unusually high or low genetic diversity in this popu-
lation (S3 Table). The most striking result of this analysis is an extended region of homozygos-
ity on chromosome 14, which includes a 10kb window with no polymorphic SNVs despite
having a mean of 6.35 samples contributing data. When we narrowed our focus to this region
by calculating y^w in overlapping windows, we found that the Dihydropteroate Synthetase gene
(dhps) was at the center of this region of low diversity (Fig 4). Although there are no polymor-
phisms within this region, all eight of our samples contain a non-reference allele resulting from
a G to C substitution in the second exon of dhps. The substitution is non-synonymous and
leads to the A383G amino acid substitution that has been associated with sulphadoxine resis-
tance in numerous previous studies of P. vivax[45]. This pattern of low diversity surrounding a
fixed substitution is the classic sign of a hard selective sweep [46, 47], in which a single mutant
or migrant allele is rapidly fixed by selection. No other non-reference alleles were present in the
dhps gene.
Most of the remaining genes that overlap with other high- or low-diversity windows encode
proteins for which there is no functional annotation. Nevertheless, the high-diversity windows
include antigen and surface protein genes such asmsp7 and vir family proteins, which are
known to be under balancing selection in P. vivax[19]. Because our conservative variant calling
approach removed difficult-to-align multi-copy gene families, it is likely we excluded other
genes under balancing selection.
We also examined other genes thought to be involved in drug resistance in P. vivax
(Table 6). Alleles of the dihydrofolate reductase (dhfr) gene are known to confer resistance to
pyrimethamine, a drug administrated together with sulphadoxine (SP). We did not observe
evidence of a selective sweep at the dhfr locus. However, all samples for which a genotype could
be called reliably (six of eight) have non-synonymous SNVs leading to both S58R and S117N
amino acid substitutions. Both of these substitutions have been associated with SP resistance in
P. vivax[45]. There are two distinct nucleotide variants encoding the S58R substitutions in our
population samples, with three parasites having AGC>AGAmutations in the 58th codon, and
three others having an AGC>CGC mutation. We found a total of 13 additional non-synony-
mous variants in the ATP-cassette binding proteins (pvmdr1 and PVX_124085, a homolog of
Fig 4. A selective sweep around dhps. Twomeasures of genetic diversity (y-axis), were calculated in overlapping windows across a portion of
Chromosome 14 (positions in x-axis). The dashed path under the x-axis represents the position of exons in the current annotation of the P. vivax reference
genome. Exons of dhps are shaded black, all others are shaded gray. Dashed lines represent the genome-wide average of each diversity measure.
doi:10.1371/journal.pntd.0004252.g004
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P. falciparum mrp proteins). There were no such variants in GTP cyclohydrase, chloroquine
resistance transporter ortholog, or Kelch 13, which are all considered possible drug resistance
genes [18].
Discussion
Genetic diversity in Colombia
The genetic diversity estimated from our Colombian P. vivax population is similar to, though
slightly lower than, estimates derived from a global sample of P. falciparum (where y^w has been
estimated to be 1.03 × 10−3 using isolates from Africa, America, Asia and Oceania [48]).
Although it is well known that P. vivax is more genetically diverse than P. falciparum globally,
this finding is important as it demonstrates that P. vivax control programs face genetically
diverse populations even in relatively small spatial scales in South America.
It is difficult to compare the genetic diversity of our sample to that of other P. vivax popula-
tions. Most studies that report estimates of genetic diversity for this species are focused on clin-
ically important epitopes or a few markers. On the other hand, whole-genome studies cannot
usually report diversity statistics due to multiplicity of infection in their samples. However, we
can compare our heterozygosity estimates to those produced from one large scale population
genetic study. A study using 5.6 kb of non-coding DNA from P. vivax isolates from across
India [49] reported y^w values ranging (from 1.3 × 10
−3—3 × 10−3. These values are somewhat
higher than our diversity estimates from introns (y^w 7:9 104) or intergenic regions
(y^w ¼ 7:5 104) but within the range of values we calculate from 10kb windows.
Table 6. Non-synonymous variants at drug resistance loci.
Locus Chromosome Position Codon Amino Acid Number of samples
dhps 14 1257856 gCc/gGc A383G 8 (8)
dhfr 5 964761 Agc/Cgc S58R* 4 (7)
5 964763 agC/agA* S58R* 3 (7)
5 964939 aGc/aAc S117N* 6 (6)
pvmdr1 10 363169 tAc/tTc Y976F 3 (8)
10 363223 aCg/aTg* T958M* 8 (8)
10 363374 Atg/Ctg M908L 8 (8)
10 364598 Gat/Aat D500N 4 (8)
10 365435 Gtg/Ttg V221L 5 (8)
PVX_124085 14 2043859 Caa/Gaa* Q1419E* 1 (7)
14 2044528 Ccg/Tcg P1196S 3 (8)
14 2044798 Gcg/Tcg* A1106S* 2 (6)
14 2044975 Ctg/Atg L1047M 1 (7)
14 2045050 Gtg/Atg* V1022M* 7 (7)
14 2046072 aGc/aTc S681I 3 (6)
14 2047233 aGg/aTg* R294M* 7 (7)
14 2047816 Gaa/Caa* E100Q* 2 (6)
“Number of samples” refers to the number of genomic sequences that contained this allele in the present study, the number of samples from which any
allele could be reliably called appears in parentheses. Variants marked with an asterisk were also recorded from a population in the Amazon basin in Peru
[18]. Note the numbering of amino acid substitutions in PVX_124085 differs between these studies as a result of the different annotations used in each
case.
doi:10.1371/journal.pntd.0004252.t006
Colombian Plasmodium vivaxGenomes Have Substantial Genetic Diversity
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004252 December 28, 2015 12 / 21
We can also make a crude comparison between our results and those from other whole-
genome studies [18, 31] by comparing the number of non-reference alleles found in each popu-
lation. Despite our relatively small number of well-covered samples, restricted geographic
range, and the conservative approach to variant calling, we detected 33,855 SNVs. When we
apply the same masking criteria used in this study to the variants reported from an unknown
number of parasite lineages from Cambodia and Madagascar we arrive at comparable number
of SNVs (41,630 and 45,417 respectively). Our study discovered considerably more variants
than a recent study of P. vivax isolates from the Amazon basin in Peru (10,989 variants). It is
likely that this difference reflects the low genetic diversity of the particular Peruvian population
studied. Simply counting non-reference alleles does not provide a direct comparison of genetic
diversity between populations, especially when the number of parasite lineages sampled in
other studies is not known. Nevertheless, these results demonstrate the Colombian population
sampled here does not contain an unusually low number of non-reference alleles as might be
expected from a population with low genetic diversity.
Comparing the whole-genome studies also highlights the degree of allele-sharing among
populations (Fig 3). Approximately two-thirds of the SNVs detected from a P. vivax population
in Peru were also detected in our Colombian samples, and 11,618 alleles are shared by the
Cambodian and Madagascan populations but absent from both South American samples. This
pattern may represent genetic differentiation between NewWorld and Old World populations,
although it is important to note that differences between these studies may also reflect different
variant calling procedures. A complete understanding of the global structure of P. vivax popu-
lations, and the relative diversity of populations on different continents, will require many
more population samples and a consistent approach to variant calling.
Together these findings differ substantially from the perception that South American P.
vivax populations in general have low diversity as a result of a simple evolutionary history [19,
20]. Some populations, including the Peruvian population discussed above, do indeed have low
genetic diversity, which may be the result of recent local introductions or expansions from a few
founders following malaria control programs [50]. On the other hand, the Colombian popula-
tion studied here has substantial genetic diversity. It has been suggested that such diversity
could be result of complex demographic processes involving multiple introductions and admix-
ture among lineages in broad temporal and spatial scales [20]. A comprehensive population
genomic study of South America would be required to understand the extent of such genetic
polymorphism and the processes involved in its maintenance. Nevertheless, our results demon-
strate that South American P. vivax populations do not universally have low genetic diversity.
Our heterozygosity estimates are calculated under the assumption that each sampled patient
was infected by a single parasite lineage. If multiple P. vivax lineages were present in some patient
samples our estimates may be inflated. However, we do not believe this is likely. None of our sam-
ples show the excess of intermediate frequency bases expected to arise from sequencing of mixed
infections (Fig 2). Furthermore, our lowest coverage samples, which would be most likely to gen-
erate extra variant calls if multiple infections were present, do not produce an excess of rare bases
or singletons SNVs. The apparent lack of multiple infections among our patient samples may
reflect local conditions in Córdoba, including seasonal transmission of the disease and the wide-
spread use of primaquine, a drug that eliminates dormant infections. Indeed, three of our patients
are known to have received primaquine in the 12 months prior to providing their sample.
Signatures of natural selection
We identified genomic windows with exceptionally high or low genetic diversity. High genetic
diversity may be maintained by balancing selection, while regions of low diversity may be subject
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to strong purifying selection or be the product of recent selective sweeps. The majority of genes
contained within these windows encode proteins for which little is known. However, some of the
high diversity windows overlap with antigen and surface protein genes that are thought to be sub-
ject to balancing selection in P. vivax globally [19]. It is possible that genes in other windows of
exceptional diversity have likewise been subject to natural selection; this could be confirmed with
a larger population sample and thus a statistically more powerful genome scan.
We also looked at patterns of diversity more broadly by comparing results from different
genomic features. All measures of diversity were lowest in exon sequences, followed by
untranslated regions, intergenic spaces, and introns. This pattern, along with the relative lack
of non-synonymous SNVs, is consistent with earlier studies demonstrating that purifying selec-
tion has a strong effect on protein coding genes in P. vivax[51]. It is interesting to note that our
estimates of genetic diversity were higher for introns than intergenic regions. This pattern has
been reported in P. falciparum[19]; it may reflect the presence of conserved, but unannotated,
genes in what are currently considered intergenic regions [48].
Drug resistance alleles in Colombia
Our analysis of low diversity regions revealed a selective sweep associated with the A383G allele
of dhps, which has previously been associated with resistance to sulfadoxine [45]. Although
resistance to SP treatment, and indeed resistance mediated by this particular mutation, is a well
known phenomenon, this result is interesting for two reasons. First, by identifying a selective
sweep around this mutation we are able to demonstrate that SP resistance has arisen within
Colombia via the rapid fixation of a single allele. This finding, combined with the fact that
another dhps allele (A385G) is most commonly associated with SP resistance in Madagascar
[52], French Guiana [52], India [53], Iran [54], Pakistan [55], Thailand [56] and China [57],
suggests SP resistance has come about through multiple independent origins. Similar repeated
evolution of dhps resistant mutations has been reported in P. falciparum[58–61]
The evolution of SP resistance is also interesting in an operational context because it dem-
onstrates that this P. vivax population has been subject to drug pressure from SP, a drug that
has not been part of the approved treatment for uncomplicated P. vivaxmalaria in Colombia
(where the drugs of choice are still chloroquine-primaquine combination therapy). SP has
been used to treat P. falciparum infections in Colombia, so it is possible this selective pressure
has arisen from misdiagnosis of P. vivax infections or the use of SP to treat mixed P. vivax-P.
falciparum infections. It is also possible that poor compliance with national drug policies,
including self-medication by some patients with access to antifolates, or the long half-life of
antifolate drugs could lead to P. vivax infections coming into contact with SP.
The region surrounding the dhfr does not show the pattern of decreased genetic diversity
associated with a hard selective sweep. In this case, all genotyped samples have two SP-resis-
tance alleles (S58R and S117N), with the first allele encoded by two distinct SNVs. Thus, SP-
resistance alleles in each gene have somewhat different histories, with dhps A383G entering the
population once and being rapidly driven toward fixation, but dhfr resistance arising from two
separate alleles that have been maintained in the population. This pattern differs from the one
found in P. falciparum, where dhfrmutations associated with drug resistance are fixed as the
result of a selective sweep, whereas dhpsmutations are still segregating with sensitive alleles in
the population [59, 61].
We detected non-synonymous variants in two other genes thought to be involved with drug
resistance in Plasmodium species. There are eight non-synonymous variants in PVX_124085.
The phenotypic effects of these variants are not known, but the changes to a P. falciparum
homolog of this gene have been associated with decreased sensitivity of primaquine [62] and
Colombian Plasmodium vivaxGenomes Have Substantial Genetic Diversity
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004252 December 28, 2015 14 / 21
antifolate drugs [63]. This study is the third time that an excess of non-synonymous mutations
in this gene has been recorded from a population in South America [18, 64]; the clinical signifi-
cance of this repeated finding should be investigated.
We identified five non-synonymous mutations in pvmdr1, three of which are known from
populations in Asia and Madagascar [52, 65]. Mutations in the P. falciparum ortholog of this
gene are associated with decreased sensitivity to chloroquine, and pvmdr1 variants are thus
considered putative chloroquine-resistance alleles. Among the variants we report, only Y976F
has been associated with decreased sensitivity to chloroquine (in vitro and with a modest effect
size) [66]. There is little evidence for drug failure with chloroquine in South America at present.
Nevertheless, the presence of these alleles in a South American population warrants further
investigation and presents an opportunity to test for an association between pvmdr1 alleles and
sensitivity to the drug in a clinical setting.
We also compared the variants we report from putative drug resistance genes with those
reported from another South American population in the Amazon basin of Peru (Table 6).
These populations share many alleles, including both SP resistane alleles in dhfr and five amino
acid substitutions in PVX_124085. In contrast, four of the five variants we reported from
pvmdr1 are not present in the Peruvian population and there are no non-synonymous substitu-
tions in Peruvian dhps sequences. These results demonstrate the importance of local informa-
tion in designing control programs, as each population contains distinct drug resistance alleles
that may generate distinct responses to different treatments. In addition, the fact that two pop-
ulations separated by a considerable geographical distance, as well as by the Andes, share mul-
tiple alleles that are identical by state at the nucleotide level, suggests that it is possible for drug
resistance alleles to spread by gene flow between distant populations in South America.
Microsatellite loci for P. vivax studies in the Americas
Although population genomic studies offer a unique view into the biology of P.vivax, smaller-
scale studies that use genotypes from only a few loci will remain important in malaria research.
One important result from this study is a set of new microsatellite loci that can be used in fine
scale population genetic and molecular epidemiological studies in Colombia. Microsatellite loci
are particularly useful for such studies, as their relatively high mutation rates can generate
highly polymorphic loci. As a result, population genetic signals in microsatellite loci can reflect
demographic events occurring at short time scales, including epidemiological events [50, 67].
These markers can also be used for population assignment and in testing for multiple infections
[21, 22, 68, 69].
Thus far, 160 microsatellites have been found in the genome of P. vivax[22]; however, many
of these loci fail to amplify in some populations [21, 22]. It is not surprising that loci developed
in one region are not necessarily informative in others: microsatellites have complex evolution-
ary histories [70] and high potential for homoplasy [71]. Thus, the widespread application of
microsatellite loci to epidemiological problems will require the development of new markers
known to amplify and be polymorphic within specific populations. We found 789 putatively
polymorphic microsatellite loci from our whole-genome sequencing, demonstrating that the
160 markers currently used in P. vivax represent only a small proportion of loci available in
this species. Moreover, we demonstrated that the loci we detected in our whole-genome
sequencing can be developed into useful makers. The 18 markers we developed yield patterns
of repeats that are easy to score in populations in the Pacific Coast of Colombia and show high
levels of polymorphism. Whether these markers will be useful at broader geographic scales
remains to be seen, but the specific markers we developed will be useful for fine-scale studies in
this region, where malaria elimination is currently being considered.
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Conclusion
Our results add to growing evidence that P. vivax populations are genetically diverse. Even at a
small spatial scale in Colombia, this P. vivax population harbors levels of genetic diversity simi-
lar to a global sample of P. falciparum. The diversity we observed appears to be inconsistant
with demographic scenarios in which South American P. vivax populations were derived from
a recent introduction, possibly associated with a severe population bottleneck [17, 72]. As such,
our study lends further support to the idea that P. vivax populations in the Americas have a
more complex history than was previously thought [20].
Our study also demonstrates that genomic studies of natural populations of P. vivax can
provide insights into how parasite populations react to control strategies. Specifically, we iden-
tified a selective sweep associated with resistance for SP, a drug that is not used to treat P. vivax
in Colombia. This resistance indicates a possible spillover effect from a drug that is primarily
used to treat P. falciparum. The operational consequences of these results require additional
investigations. Future studies with additional samples may detect additional regions under
selection and thus contribute to the identification of vaccine targets [73] or other clinically rele-
vant phenotypes. Finally, we used our genomic data to develop a set of microsatellite markers
that are both easy to genotype and known to be polymorphic within this population. These
markers will aid future epidemiological studies and our understanding of malaria transmission
and demography in Colombia.
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